Myopia arises when the eye grows too long relative to its focal length, placing the image plane in front of the retina. Research across multiple species, including chicks, guinea pigs, tree shrews, mice, and rats, has established that this axial growth is regulated by visual experience through a retina-to-sclera signaling cascade. Understanding these mechanisms is the foundation for designing pharmacological and optical interventions.
Table of Content
Placeholder element - will be replaced automatically with TOC (h2 elements in the text)
Foundations and Context
Myopia as a Growth Regulation Failure
The vertebrate eye grows postnatally toward a target refractive state close to emmetropia, a process called emmetropization. This process is visually guided: the retina detects the sign and magnitude of defocus and sends signals posteriorly through the choroid and sclera to regulate axial elongation rate. When this feedback mechanism is disrupted, either by degrading the retinal image (form deprivation) or by imposing an artificial optical defocus (lens-induced myopia), the eye fails to reach or maintain emmetropia and becomes myopic or hyperopic. The same principle applies across a broad phylogenetic range: chicks, tree shrews, guinea pigs, mice, and rats all show measurable refractive responses to manipulated visual experience, making them tractable animal models for studying this mechanism (Zheng et al., Adv Ophthalmol Pract Res. (2024)).
A central readout for tracking myopia development in these models is the refractive state, measured non-invasively by the Striatech Photorefractor, which quantifies the diopter shift over time. Pairing this with corneal curvature measurement by the Striatech Keratometer allows structural decomposition of the growing eye (Jiang et al., Advanced Science (2024)). Such a readout is widely applied in myopia and refractive development research.
The Emmetropization Feedback Loop
Emmetropization is the process by which the eye grows after birth so that images are focused exactly on the retina (a state called emmetropia, i.e., no refractive error). Emmetropization depends on the retina's ability to detect the sign of defocus: whether the image plane falls behind the retina (hyperopia, which signals the eye to grow faster) or in front of it (myopia, which signals the eye to slow growth). This sign discrimination relies on optical cues including chromatic aberration, temporal variations in image contrast, and spatial frequency content of the visual scene. The detection occurs in the retina and is relayed through a cascade of molecular signals, some of which travel without involving the brain, as demonstrated by experiments in which optic nerve section does not abolish the local refractive response to form deprivation in chicks.
The retinal signal is transmitted through the retinal pigment epithelium and choroid to the sclera, where it modulates the activity of fibroblasts alone (in fibrous sclera, as in mammals), or of fibroblasts and chondrocytes (in cartilaginous sclera, as in birds). In myopia, increased matrix metalloproteinase activity degrades scleral collagen, reducing tissue rigidity and allowing the globe to elongate under normal intraocular pressure. Compounds that inhibit scleral remodeling, or that shift the retinal signaling balance, are therefore candidate anti-myopia agents (Yin et al., Scientific reports (2025)).
Key Molecular Pathways in Experimental Myopia
Several molecular pathways have been implicated in the retina-to-sclera signaling cascade in multiple species. Dopamine, released by retinal amacrine cells in response to light exposure, suppresses eye growth; reduced dopaminergic signaling is a consistent finding in form-deprived eyes. Nitric oxide, retinoic acid, and various growth factors including BMP2 modulate the downstream scleral response. BMP2 has been shown to inhibit myopia progression in guinea pigs by upregulating PPARγ, with refractive state tracked using the Striatech Photorefractor (Cai et al., Experimental eye research (2026)).
Retinal cell-intrinsic metabolic pathways also participate. Inhibition of ALKBH5, an m6A demethylase expressed in retinal ganglion cells, attenuates myopia progression through selective effects on ERK1/2 signaling, again with refractive endpoints measured by Photorefractor (Zhu et al., Journal of translational medicine (2025)). Oxidative stress in the ciliary muscle is a convergent target in several pharmacological studies: quercetin reduces ciliary muscle remodeling in experimental myopia through SIRT1-mediated pathways (Yang et al., Biochemical pharmacology (2026)), and vitamin E alleviates ferroptosis in the ciliary muscle via ACOT7 activation (Cao et al., Investigative ophthalmology & visual science (2026)). These findings, taken together, indicate that multiple molecular entry points can modulate the final common pathway of axial elongation.
Interpreting Species Differences in Myopia Susceptibility
The magnitude and speed of experimental myopia differ substantially across species, and these differences carry practical implications for study design. Chicks are the most responsive: form deprivation for as little as a few days produces large myopic shifts measurable in tens of diopters. The chick sclera contains a cartilaginous layer not present in mammals, making it an unusually plastic growth substrate. Tree shrews develop myopia rapidly and have a cone-dominated retina, offering a photoreceptor profile closer to primates. Guinea pigs develop moderate but consistent myopia over 2-4 weeks and have several features that make them preferred for pharmacological testing (Cai et al., Experimental eye research (2026)). Mice and rats develop smaller refractive shifts in absolute diopter terms and require longer induction periods, but the availability of genetic tools in mice is a significant advantage for pathway-level questions (Insignares et al., International journal of molecular sciences (2025)).
For a structured comparison of species suitability for different experimental objectives, see "Choosing Animal Models for Optical and Myopia Research".
Connecting Mechanistic Knowledge to Experimental Design
Understanding the signaling cascade from retina to sclera guides the choice of induction paradigm. Form deprivation interrupts the visual feedback signal at the retinal detection stage by degrading image contrast. Negative lens induction shifts the defocus sign signal from hyperopic (growth-promoting) to myopic (growth-inhibiting) in the opposite direction from what is needed for emmetropization. Both paradigms converge on the same downstream scleral remodeling pathway, but may engage different proximal signaling steps. Researchers targeting retinal mechanisms (such as dopamine or ALKBH5) may find that the magnitude and time course of the response to both paradigms informs the molecular timeline.
For induction paradigm protocols and the measurement workflows used to track refractive progression, see "Form Deprivation and Lens-Induced Myopia Models". For pharmacological intervention study design, see "Atropine and Pharmacological Intervention Workflows".
Gaps and Caveats in Current Mechanistic Knowledge
Despite extensive research, several steps in the emmetropization signaling cascade remain incompletely understood, particularly in mammals. The identity of the primary refractive error detector in the mammalian retina is not fully resolved. The relative contributions of local retinal signaling versus central visual pathways differ across species and may affect how pharmacological interventions extrapolate from one model to another. Scleral structure differences between species (cartilaginous versus fibrous) mean that scleral-targeted agents effective in chicks may have different effects in guinea pigs or mice.
Studies using the Striatech Photorefractor and Keratometer provide functional and structural endpoints in vivo, but do not directly report molecular events. Tissue collection for molecular analysis at the end of a longitudinal optical study allows correlation of the diopter and curvature trajectories with scleral gene expression or protein levels, linking the optical phenotype to its molecular substrate (Yin et al., Scientific reports (2025)).
Key Takeaways
1
2
3
4
5
6
7
Answers to the most frequent questions
01What is emmetropization and why does it fail in myopia?
Answer
Emmetropization is the visually guided postnatal process by which the eye adjusts its axial length to match its focal length, achieving clear focus (emmetropia). It fails in myopia when the retina's defocus detection or the downstream signaling to the sclera is disrupted, allowing excessive axial elongation. Both environmental factors (degraded visual input, sustained near work) and genetic predispositions can impair this feedback loop.
02How does form deprivation differ from lens-induced myopia as an induction paradigm?
Answer
Form deprivation removes patterned visual input entirely (for example, by fitting a diffuser), depriving the retina of the contrast information needed for emmetropization. Lens induction uses a negative (concave) lens to shift the focal plane, making the eye behave as if it needs to grow longer to refocus. Both paradigms ultimately drive axial elongation, but they engage the emmetropization signaling cascade at different steps. For detailed treatment of both paradigms, see "Visual Environment and Refractive Development".
03Why do chicks develop myopia so much faster and larger than mice or rats?
Answer
Chicks have a cartilaginous scleral layer that is highly plastic and responds to growth signals within hours to days. Their emmetropization system is extremely sensitive to visual perturbation. Mice and rats have fibrous-only sclerae that remodel more slowly, and their eyes are smaller in absolute size, limiting the detectable diopter shift. These differences mean that chick studies can detect mechanistic signals more quickly but may not fully replicate the molecular targets relevant to mammalian (including human) myopia.
04What role does dopamine play in eye growth regulation?
Answer
Dopamine, released by retinal amacrine cells in response to light exposure, acts as a growth-suppressive signal: it inhibits axial elongation. Form-deprived eyes show reduced dopamine release, and exogenous dopamine agonists can attenuate experimental myopia in several species. This is one reason that increased outdoor time, which raises retinal illuminance and dopamine release, is associated with reduced myopia progression in children. Animal studies measuring refractive progression with the Photorefractor have been used to evaluate compounds that modulate retinal dopaminergic signaling.
05What does the Striatech Photorefractor measure that makes it useful for tracking myopia development?
Answer
The Striatech Photorefractor measures refractive state in diopters using infrared eccentric photorefraction in alert, unsedated animals. It provides a non-invasive, repeatable, and automated readout of the net optical outcome of all growth changes in the eye. This makes it the primary longitudinal endpoint in animal myopia studies, enabling the detection of progressive myopic shifts across sessions without sacrificing animals or using anesthesia (Cai et al., Experimental eye research (2026)).
06Can tree shrews be used as a myopia model and how do they compare to other species?
Answer
Yes, tree shrews (Tupaia glis) are a well-established mammalian myopia model. They have a cone-dominated retina similar in some respects to primates, develop myopia relatively quickly under form deprivation, and have been used extensively to study scleral remodeling mechanisms. Their main limitation is that they are less commercially available than mice or guinea pigs and are not as amenable to genetic manipulation as mice. Their cone-rich retina makes them particularly useful for studies of photoreceptor-level signaling in emmetropization.
Further Reading
Related "Background and Methods" Articles
Related "Applications" Articles
References
- Photorefractor
- Photorefractor
- Photorefractor
- Photorefractor
- Photorefractor
- OptoDrum